Mefunidone ameliorates lipopolysaccharide-induced acute lung injury through inhibiting MAPK signaling pathway and enhancing Nrf2 pathway.

Author List

Yao TT, Zhang Y, He RL, Lv X, He YJ, Li MY, Han YY, Long LZ, Jiang GL, Cheng XY, Hu GY, Li QB, Tao LJ, Meng J

Publication

Publication ID (Profile URL)

https://researcherprofiles.org/profile/679813918

Publication Year

2022

PubMed ID

36334370